Trichomoniasis

Causative Organism and Transmission

Trichomoniasis is a widespread sexually transmitted infection caused by Trichomonas vaginalis, a flagellated protozoan parasite. This organism primarily infects the squamous epithelium of the lower genital tract, including the vagina, urethra, and endocervix in women, as well as the urethra and prostate in men. Transmission occurs almost exclusively through unprotected vaginal intercourse. The parasite cannot survive for long periods on inanimate objects like toilet seats, meaning non-sexual transmission is exceedingly rare. In Nigerian clinical practice, midwives frequently encounter this infection among women presenting with abnormal vaginal discharge, making it one of the most common non-viral STIs managed in primary healthcare clinics.

Clinical Presentation in Women and Men

The clinical manifestations of trichomoniasis vary widely, with a large proportion of infected individuals remaining completely asymptomatic. When symptoms do appear, they differ between sexes.

• In women: Typical signs include a diffuse, malodorous, yellow-green or gray vaginal discharge, often accompanied by vulvar itching, burning, and dyspareunia. On speculum examination, the classic finding is the strawberry cervix (punctate hemorrhages on the ectocervix), though this appears in only a minority of cases.
• In men: Most infected males are asymptomatic carriers. When symptomatic, they may present with mild urethral pruritus, a clear or purulent discharge, and dysuria.

Diagnosis in Clinical Practice

Diagnosing trichomoniasis requires clinical suspicion confirmed by laboratory tests, as symptoms overlap heavily with other vaginal infections like candidiasis and bacterial vaginosis.

1. Wet Mount Microscopy: The traditional and most accessible method in many Nigerian clinics involves mixing vaginal secretions with normal saline on a glass slide and examining it under a microscope to observe motile, flagellated trichomonads. However, its sensitivity is relatively low, dropping further if samples are not examined promptly.
2. Culture: Historically considered the gold standard, culture is reliable but takes several days for results.
3. Molecular Testing: Nucleic Acid Amplification Tests (NAATs) offer the highest sensitivity and specificity, detecting parasite DNA from vaginal swabs or urine samples, though cost and equipment availability can limit routine use in resource-constrained settings.

Medical Management and Treatment

The standard pharmacological treatment for trichomoniasis relies on systemic nitroimidazole antimicrobials. Metronidazole and tinidazole are the cornerstone drugs, usually administered orally as a single dose or a multi-day course. Oral treatment is preferred because it achieves therapeutic levels in the urethra and endocervix, where the parasite also resides.

Midwives must counsel patients on crucial lifestyle modifications during treatment. Consuming alcohol while taking nitroimidazoles can trigger a severe disulfiram-like reaction characterized by flushing, nausea, and vomiting. Furthermore, patients must abstain from sexual intercourse until both they and their partners have completed treatment and are entirely free of symptoms to prevent immediate reinfection.

Implications for Pregnancy

In pregnant women, untreated trichomoniasis poses significant risks to maternal and fetal wellbeing. The infection is strongly associated with adverse obstetric outcomes, including premature rupture of membranes (PROM), preterm delivery, and the delivery of low birth weight infants. Additionally, local inflammation caused by the parasite can weaken fetal membranes and increase local susceptibility to acquiring or transmitting HIV. Midwives play a vital role in antenatal care by screening symptomatic women, treating diagnosed infections promptly, and educating mothers on why completing the prescribed course is essential for a safe pregnancy outcome.

Partner Notification and Prevention

Managing trichomoniasis successfully requires addressing the sexual partner simultaneously. Because reinfection rates are exceptionally high when partners remain untreated, simultaneous treatment of all recent sexual contacts is mandatory, regardless of whether they show symptoms. Midwives should provide partner notification slips or counseling strategies that encourage open communication. Preventive measures focus on consistent and correct condom use, early screening during routine antenatal visits, and prompt health-seeking behavior at the first sign of unusual genital discharge or discomfort.